ID

12998

Descripción

Randomized Trial of Follow-up Strategies in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00156039

Link

https://clinicaltrials.gov/show/NCT00156039

Palabras clave

Versiones (1)
  1. 10/1/16 10/1/16 -
Subido en

10 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00156039

Inglés

Eligibility Breast Cancer NCT00156039

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
women with breast cancer on well follow-up at regional cancer centres in ontario and manitoba
Descripción

Gender, breast cancer, follow up

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0678222
UMLS CUI [3]
C1522577
diagnosed at least 12 months previously (range 9-15 months)
Descripción

date of diagnosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C1274082
without evidence of active disease (i.e., stages iiib and iv excluded)
Descripción

no active disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2707252
free from any primary treatment complications
Descripción

treatment complications

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0679861
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
primary treatment at least 3 months previously, except for continued use of tamoxifen
Descripción

primary treatment date, tamoxifen

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0011008
UMLS CUI [2]
C0039286
still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
Descripción

complications of primary treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0679861
UMLS CUI [2]
C1708063
unable to identify an acceptable family physician to provide follow-up
Descripción

family physician to provide follow-up

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522577
language or literacy skills inconsistent with completing questionnaires
Descripción

language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1145677
unable to comply with study protocol including completion of questionnaires
Descripción

unable to comply

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
Descripción

study participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
actively followed at a cancer centre for another primary cancer
Descripción

malignancies

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00156039

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender, breast cancer, follow up
Item
women with breast cancer on well follow-up at regional cancer centres in ontario and manitoba
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
C1522577 (UMLS CUI [3])
date of diagnosis
Item
diagnosed at least 12 months previously (range 9-15 months)
boolean
C2316983 (UMLS CUI [1,1])
C1274082 (UMLS CUI [1,2])
no active disease
Item
without evidence of active disease (i.e., stages iiib and iv excluded)
boolean
C2707252 (UMLS CUI [1])
treatment complications
Item
free from any primary treatment complications
boolean
C0679861 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
primary treatment date, tamoxifen
Item
primary treatment at least 3 months previously, except for continued use of tamoxifen
boolean
C1708063 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
complications of primary treatment
Item
still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
boolean
C0679861 (UMLS CUI [1])
C1708063 (UMLS CUI [2])
family physician to provide follow-up
Item
unable to identify an acceptable family physician to provide follow-up
boolean
C1522577 (UMLS CUI [1])
language
Item
language or literacy skills inconsistent with completing questionnaires
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1145677 (UMLS CUI [1,3])
unable to comply
Item
unable to comply with study protocol including completion of questionnaires
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
study participation status
Item
previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
boolean
C2348568 (UMLS CUI [1])
malignancies
Item
actively followed at a cancer centre for another primary cancer
boolean
C0006826 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial